Dysregulation of NAD+ metabolism has been increasingly implicated in cancer development and progression, suggesting that SLC25A51 may serve as a critical mediator linking mitochondrial metabolism to tumorigenesis 15. The gene discussed is SLC25A51; the disease is cancer.